Loading...

Matthew Worley

TitleAssistant Adjunct Professor
InstitutionUniversity of California San Diego
DepartmentPsychiatry
Address9500 Gilman Drive #0930
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Behavioral economic mechanisms of prescription opioid addiction in chronic pain
    NIH/NIDA K23DA039348Apr 1, 2016 - Mar 31, 2021
    Role: Principal Investigator
    Mediators of Outpatient Treatment for Comorbid Substance Use Disorder and Major D
    NIH/NIDA F31DA030861Jan 25, 2011 - Jan 24, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Worley MJ, Swanson AN, Heinzerling KG, Roache DJO, Shoptaw S. Corrigendum to "Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study" [Drug Alcohol Depend. 162 (2016) 245-250]. Drug Alcohol Depend. 2018 Jul 12; 190:120. PMID: 30014886.
      View in: PubMed
    2. Briones M, Shoptaw S, Cook R, Worley M, Swanson AN, Moody DE, Fang WB, Tsuang J, Furst B, Heinzerling K. Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial. Drug Alcohol Depend. 2018 May 25; 189:30-36. PMID: 29860057.
      View in: PubMed
    3. Worley MJ, Isgro M, Heffner JL, Lee SY, Daniel BE, Anthenelli RM. Predictors of reduced smoking quantity among recovering alcohol dependent men in a smoking cessation trial. Addict Behav. 2018 May 09; 84:263-270. PMID: 29763835.
      View in: PubMed
    4. Worley MJ, Fei K, Lopez-Denman AJ, Kelleher AD, Kent SJ, Chung AW. Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC. J Immunol Methods. 2018 Jun; 457:41-52. PMID: 29605231.
      View in: PubMed
    5. Courtney KE, Worley M, Castro N, Tapert SF. The effects of alcohol hangover on future drinking behavior and the development of alcohol problems. Addict Behav. 2018 Mar; 78:209-215. PMID: 29216570.
      View in: PubMed
    6. Granholm E, Holden J, Worley M. Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs. Schizophr Bull. 2017 Aug 03. PMID: 29036391.
      View in: PubMed
    7. Nguyen-Louie TT, Brumback T, Worley MJ, Colrain IM, Matt GE, Squeglia LM, Tapert SF. Effects of sleep on substance use in adolescents: a longitudinal perspective. Addict Biol. 2018 Mar; 23(2):750-760. PMID: 28547821.
      View in: PubMed
    8. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. PMID: 28357460.
      View in: PubMed
    9. Isgro M, Doran N, Heffner JL, Wong E, Dinh E, Tibbs J, Russell K, Bittner T, Wehrle C, Worley MJ, Anthenelli RM. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men. J Stud Alcohol Drugs. 2017 Mar; 78(2):232-240. PMID: 28317503.
      View in: PubMed
    10. Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction. 2017 Jul; 112(7):1202-1209. PMID: 28164407.
      View in: PubMed
    11. Anthenelli RM, Heffner JL, Wong E, Tibbs J, Russell K, Isgro M, Dinh E, Wehrle C, Worley MJ, Doran N. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men. Alcohol Clin Exp Res. 2017 Jan; 41(1):197-206. PMID: 28029173.
      View in: PubMed
    12. Brumback TY, Worley M, Nguyen-Louie TT, Squeglia LM, Jacobus J, Tapert SF. Neural predictors of alcohol use and psychopathology symptoms in adolescents. Dev Psychopathol. 2016 11; 28(4pt1):1209-1216. PMID: 27739397.
      View in: PubMed
    13. Luk JW, Worley MJ, Winiger E, Trim RS, Hopfer CJ, Hewitt JK, Brown SA, Wall TL. Risky driving and sexual behaviors as developmental outcomes of co-occurring substance use and antisocial behavior. Drug Alcohol Depend. 2016 12 01; 169:19-25. PMID: 27750183.
      View in: PubMed
    14. Worley MJ, Heinzerling KG, Roche DJ, Shoptaw S. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. Drug Alcohol Depend. 2016 May 01; 162:245-50. PMID: 26993372.
      View in: PubMed
    15. Choi TK, Worley MJ, Trim RS, Howard D, Brown SA, Hopfer CJ, Hewitt JK, Wall TL. Effect of adolescent substance use and antisocial behavior on the development of early adulthood depression. Psychiatry Res. 2016 Apr 30; 238:143-149. PMID: 27086224.
      View in: PubMed
    16. Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Exp Clin Psychopharmacol. 2015 Dec; 23(6):428-35. PMID: 26302337; PMCID: PMC4658240 [Available on 12/01/16].
    17. Trim RS, Worley MJ, Wall TL, Hopfer CJ, Crowley TJ, Hewitt JK, Brown SA. Bivariate Trajectories of Substance Use and Antisocial Behavior: Associations with Emerging Adult Outcomes in a High-Risk Sample. Emerg Adulthood. 2015 Aug 01; 3(4):265-276. PMID: 26889401.
      View in: PubMed
    18. Worley MJ, Witkiewitz K, Brown SA, Kivlahan DR, Longabaugh R. Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study. Alcohol Clin Exp Res. 2015 Jan; 39(1):93-100. PMID: 25623409; PMCID: PMC4418469.
    19. Worley MJ, Shoptaw SJ, Bickel WK, Ling W. Using behavioral economics to predict opioid use during prescription opioid dependence treatment. Drug Alcohol Depend. 2015 Mar 01; 148:62-8. PMID: 25622776; PMCID: PMC4666717.
    20. Khoddam R, Worley M, Browne KC, Doran N, Brown SA. Family history density predicts long term substance use outcomes in an adolescent treatment sample. Drug Alcohol Depend. 2015 Feb 01; 147:235-42. PMID: 25533896; PMCID: PMC4297729.
    21. Worley MJ, Trim RS, Tate SR, Roesch SC, Myers MG, Brown SA. Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: disentangling person and time-level effects. Psychol Addict Behav. 2014 Dec; 28(4):1220-9. PMID: 25347018; PMCID: PMC4651972.
    22. Worley MJ, Tate SR, Granholm E, Brown SA. Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression. J Consult Clin Psychol. 2014 Jun; 82(3):418-28. PMID: 24588403; PMCID: PMC4651969.
    23. Swanson AN, Shoptaw S, Heinzerling KG, Wade AC, Worley M, McCracken J, Wilson SA, Asarnow J, London ED. Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Subst Use Misuse. 2013 Dec; 48(14):1553-62. PMID: 23822739.
      View in: PubMed
    24. Worley MJ, Tate SR, McQuaid JR, Granholm EL, Brown SA. 12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Subst Abus. 2013; 34(1):43-50. PMID: 23327503; PMCID: PMC3558836.
    25. Worley MJ, Tate SR, Brown SA. Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression. Addiction. 2012 Nov; 107(11):1974-83. PMID: 22578037; PMCID: PMC3466338.
    26. Worley MJ, Trim RS, Roesch SC, Mrnak-Meyer J, Tate SR, Brown SA. Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. J Subst Abuse Treat. 2012 Oct; 43(3):291-302. PMID: 22406052; PMCID: PMC3382030.
    27. Bekman NM, Goldman MS, Worley MJ, Anderson KG. Pre-adolescent alcohol expectancies: critical shifts and associated maturational processes. Exp Clin Psychopharmacol. 2011 Dec; 19(6):420-32. PMID: 21942260; PMCID: PMC3777425.
    28. Mrnak-Meyer J, Tate SR, Tripp JC, Worley MJ, Jajodia A, McQuaid JR. Predictors of suicide-related hospitalization among U.S. veterans receiving treatment for comorbid depression and substance dependence: who is the riskiest of the risky? Suicide Life Threat Behav. 2011 Oct; 41(5):532-42. PMID: 21815915; PMCID: PMC3821394.
    29. Doran N, Sanders PE, Bekman NM, Worley MJ, Monreal TK, McGee E, Cummins K, Brown SA. Mediating influences of negative affect and risk perception on the relationship between sensation seeking and adolescent cigarette smoking. Nicotine Tob Res. 2011 Jun; 13(6):457-65. PMID: 21436297; PMCID: PMC3103719.
    30. Worley MJ, Trim RS, Tate SR, Hall JE, Brown SA. Service utilization during and after outpatient treatment for comorbid substance use disorder and depression. J Subst Abuse Treat. 2010 Sep; 39(2):124-31. PMID: 20598832.
      View in: PubMed
    31. Worley M, Gallop R, Gibbons MB, Ring-Kurtz S, Present J, Weiss RD, Crits-Christoph P. Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. Am J Addict. 2008 May-Jun; 17(3):209-17. PMID: 18463998; PMCID: PMC2794690.